Articles
How can researchers navigate the complexity of RNA drug discovery
RNA therapeutics are becoming increasingly complex through chemical modifications, delivery strategies, and diverse RNA modalities such as mRNA, siRNA, ASOs, and circRNA.
What are the challenges in antibody drug discovery — and how can they be addressed
Antibody discovery requires optimization across multiple dimensions, including target engagement, functional activity, immunogenicity, and developability.
What drives successful small-molecule drug discovery today
Small-molecule discovery is evolving beyond traditional approaches, with AI, expanded chemical space, and emerging modalities reshaping how candidates are designed and optimized.
Empowering modern research with electronic lab notebooks
Modern research generates more data than ever — across experiments, protocols, teams, and locations. Traditional paper notebooks can make that information difficult to search, secure, share, and reuse.
Optimize Vaccine Development with Peptones
Peptones support efficient and scalable vaccine manufacturing by improving cell growth, enhancing viral production, and reducing reliance on serum-based media.
Optimizing Multiplex qPCR: TaqMan QSY and QSY2 Probes vs. IDT Probes
The new Applied Biosystems™ TaqMan™ QSY™2 probes enhance multiplexing capabilities, allowing users to detect up to six targets in a single real-time PCR (qPCR) reaction with increased sensitivity, dynamic range, and performance consistency
Revolutionize Drug Development with AI/ML
Poor solubility remains one of the most significant challenges in drug development, affecting over 70% of molecules and hindering their path to clinical trials.
Accelerate Drug Development with In Silico Modeling
The path to successful drug development is filled with challenges, from managing complex molecules to ensuring bioavailability and regulatory compliance.
Recombinant Antibody Technology
Recombinant antibody technology addressed many problems associated with hybridoma-based platforms for biologics production, opening the door to new classes of drugs.
Advancing Drug Discovery: Integrating 3D Spheroid Models and Live-Cell Analysis for Compound Screening
Phenotypic screening, which measures defined changes in cellular phenotype in response to a multitude of compounds, is essential in early-stage drug discovery.
